We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Assisted GI Endoscopy Enables Accurate Detection of Colorectal Cancer

By HospiMedica International staff writers
Posted on 19 Aug 2024

Colorectal cancer is among the most prevalent cancers affecting the elderly and is increasing in frequency alongside the growth of the elderly population. More...

Early detection can facilitate timely interventions, significantly reducing morbidity and mortality associated with this disease. Currently, colonoscopies and lower gastrointestinal endoscopies are the standard methods for detecting abnormalities. However, the identification of such abnormalities is challenging due to the diverse forms of polyps, including protruding and flat types that blend into the intestinal wall. These polyps may be small and similarly colored to their surroundings, which increases the likelihood of misdiagnosis, particularly when doctors lack experience or when there is insufficient medical equipment. Statistics indicate that diagnostic error rates in such examinations can be as high as 22%. Now, a novel device designed for the rapid detection of gastrointestinal cancer delivers accurate results, enhancing preventive medicine in gastrointestinal malignancy and reducing the incidence of cancer.

The DeepGI, or Deep Technology for Gastrointestinal Tracts, developed by Chulalongkorn University (Bangkok, Thailand), is an advanced artificial intelligence (AI) tool intended to enhance the detection of abnormal polyps in the colon. Utilizing deep learning technology, DeepGI performs real-time detection and characterization of abnormalities with high accuracy, thereby augmenting the diagnostic capabilities of endoscopists. The system is compatible with various endoscopic procedures, including colonoscopy, gastroscopy, and cholangioscopy. Designed specifically for colonoscopy, DeepGI boasts a polyp detection accuracy of over 95%. In gastroscopy, it can delineate areas of Gastrointestinal Metaplasia (GIM) in the stomach, and for cholangioscopy, it can classify benign areas in real time. Thus, DeepGI offers a comprehensive solution for the entire gastrointestinal tract. Beyond mere detection, DeepGI can also differentiate between malignant (neoplastic) and benign (hyperplastic) tissues, potentially obviating the need for biopsies.

DeepGI supports a wide array of endoscopy cameras, regardless of vendor or model, facilitating its integration into existing operational setups in medical facilities. It has been validated by seasoned endoscopists who affirm its efficacy in enhancing anomaly detection rates. Currently, the technology is operational at King Chulalongkorn Memorial Hospital and is undergoing testing at several other hospitals. It has garnered international acclaim at the GI endoscopy doctors meeting, ENDO 2024, in South Korea. DeepGI holds significant promise for broader application, particularly as a support tool for endoscopists in community hospitals, where there is often a lack of medical and technological resources.

Related Links:
Chulalongkorn University


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Radiofrequency Generator
GX1
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.